Search Results - "CESKA, R"

Refine Results
  1. 1

    Treatment of hypertriglyceridemia: a review of current options by Vrablík, M, Ceska, R

    Published in Physiological research (01-01-2015)
    “…Hypertriglyceridemia is an important marker of increased levels of highly atherogenic remnant-like particles. The importance of lowering plasma levels of…”
    Get full text
    Journal Article
  2. 2

    Statin Intolerance in Clinical Practice by Snejdrlova, Michaela, Altschmiedova, T., Vrablik, M., Stulc, T., Lastuvka, J., Lanska, V., Ceska, R.

    Published in Current atherosclerosis reports (03-06-2020)
    “…Purpose of Review In our pilot study, we aimed to determine how many patients with the statin intolerance history referred to the specialized center for the…”
    Get full text
    Journal Article
  3. 3

    Biomarkers of cardiometabolic risk in obese/overweight children: effect of lifestyle intervention by Vrablík, M, Dobiášová, M, Zlatohlávek, L, Urbanová, Z, Češka, R

    Published in Physiological research (01-01-2014)
    “…Obesity is a strong cardiometabolic (CM) risk factor in children. We tested potential CM risk in obese/overweight children and the effect of an intensive…”
    Get full text
    Journal Article
  4. 4

    Statin-associated myopathy: from genetic predisposition to clinical management by Vrablik, M, Zlatohlavek, L, Stulc, T, Adamkova, V, Prusikova, M, Schwarzova, L, Hubacek, J A, Ceska, R

    Published in Physiological research (01-01-2014)
    “…Statin-associated myopathy (SAM) represents a broad spectrum of disorders from insignificant myalgia to fatal rhabdomyolysis. Its frequency ranges from 1-5 %…”
    Get full text
    Journal Article
  5. 5

    FTO and MC4R gene variants determine BMI changes in children after intensive lifestyle intervention by Zlatohlavek, L., Vrablik, M., Motykova, E., Ceska, R., Vasickova, L., Dlouha, D., Hubacek, J.A.

    Published in Clinical biochemistry (01-03-2013)
    “…This study aimed to determine whether there is a relationship between common FTO (rs17817449) and MC4R (rs17782313) gene variants and body mass reduction or…”
    Get full text
    Journal Article
  6. 6

    Gene variants at FTO, 9p21, and 2q36.3 are age-independently associated with myocardial infarction in Czech men by Hubacek, J.A., Vrablik, M., Dlouha, D., Stanek, V., Gebauerova, M., Adamkova, V., Ceska, R., Dostálová, G., Linhart, A., Vitek, L., Pitha, J.

    Published in Clinica chimica acta (15-02-2016)
    “…Cardiovascular disease (CVD) is a major cause of morbidity and mortality in developed countries. This study aimed to confirm the effect of common putative…”
    Get full text
    Journal Article
  7. 7

    ScreenPro FH: from the Czech MedPed to international collaboration. ScreenPro FH is a participating project of the EAS-FHCS by Ceska, R, Freiberger, T, Vaclova, M, Aleksicova, T, Votavova, L, Vrablik, M

    Published in Physiological research (01-01-2017)
    “…This article describes the evolution of our understanding of familial hypercholesterolemia (FH) in the Central, Eastern, and Southern Europe (CESE) region, and…”
    Get full text
    Journal Article
  8. 8

    Rosiglitazone influences the expression of leukocyte adhesion molecules and CD14 receptor in type 2 diabetes mellitus patients by Štulc, T, Svobodová, H, Krupičková, Z, Doležalová, R, Marinov, I, Češka, R

    Published in Physiological research (01-01-2014)
    “…Diabetes mellitus is associated with increased inflammatory response, which may contribute to atherosclerosis progression. Experimental results demonstrated…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Impact of variants within seven candidate genes on statin treatment efficacy by Vrablík, M, Hubáček, J A, Dlouhá, D, Lánská, V, Rynekrová, J, Zlatohlávek, L, Prusíková, M, Ceška, R, Adámková, V

    Published in Physiological research (01-01-2012)
    “…Statins are the most commonly used drugs in patients with dyslipidemia. Among the patients, a significant inter-individual variability with supposed strong…”
    Get full text
    Journal Article
  13. 13

    Strong Association between APOA5 Gene Polymorphisms and Hypertriglyceridaemic Episodes by Vrablik, M, Hubacek, J A, Dlouha, D, Satny, M, Adamkova, V, Ceska, R

    Published in Folia biologica (01-01-2019)
    “…Plasma triglyceride (TG) levels represent a significant risk factor of cardiovascular and total mortality. Concentrations of TG in the plasma depend, to a…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Therapeutic equivalence of the generic and the reference atorvastatin in patients with increased coronary risk by Boh, M, Opolski, G, Poredos, P, Ceska, R, Jezovnik, M

    Published in International angiology (01-08-2011)
    “…Generic drugs are more and more frequently used instead of originators. However, uncertainty exists with respect to therapeutic equivalence of generic product…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Leukocyte and endothelial adhesion molecules in patients with hypercholesterolemia: the effect of atorvastatin treatment by Stulc, T, Vrablík, M, Kasalová, Z, Marinov, I, Svobodová, H, Ceska, R

    Published in Physiological research (01-01-2008)
    “…Atherogenesis involves the migration of leukocytes into vascular subendothelial space, a process mediated by endothelial and leukocyte cell adhesion molecules…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Lower wall shear rate of the common carotid artery in treated type 2 diabetes mellitus with metabolic syndrome by Chytilová, E, Malík, J, Kasalová, Z, Doležalová, R, Stulc, T, Ceska, R

    Published in Physiological research (01-01-2009)
    “…Arterial sites with low wall shear stress (WSS) are more prone to the development of atherosclerotic plaques, as was observed in carotid arteries in subjects…”
    Get full text
    Journal Article
  20. 20